Yaoqi Sun

Shanghai, 200331, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Pharmacological targeting of SF3a1-MDM4 splicing vulnerability in ovarian cancer with rifaximin and antisense oligonucleotide.

Pharmacological targeting of SF3a1-MDM4 splicing vulnerability in ovarian cancer with rifaximin and antisense oligonucleotide.

Journal: Journal of translational medicine

Published: November 24, 2025

SF3a1: A Novel Potential Tumor Biomarker or Therapeutic Target.

SF3a1: A Novel Potential Tumor Biomarker or Therapeutic Target.

Journal: Journal of Cancer

Published: December 01, 2024

Sodium bicarbonate potentiates the antitumor effects of Olaparib in ovarian cancer via cGMP/PKG-mediated ROS scavenging and M1 macrophage transformation.

Sodium bicarbonate potentiates the antitumor effects of Olaparib in ovarian cancer via cGMP/PKG-mediated ROS scavenging and M1 macrophage transformation.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 07, 2024

Pixantrone as a novel MCM2 inhibitor for ovarian cancer treatment.

Pixantrone as a novel MCM2 inhibitor for ovarian cancer treatment.

Journal: European journal of pharmacology

Published: May 08, 2024

Downregulation of HNRNPA1 induced neoantigen generation via regulating alternative splicing.

Downregulation of HNRNPA1 induced neoantigen generation via regulating alternative splicing.

Journal: Molecular medicine (Cambridge, Mass.)

Published: February 05, 2024

Tyrosine hydroxylase inhibits HCC progression by downregulating TGFβ/Smad signaling.

Tyrosine hydroxylase inhibits HCC progression by downregulating TGFβ/Smad signaling.

Journal: European journal of medical research

Published: December 06, 2023

Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.

Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.

Journal: Biomolecules

Published: November 26, 2022

Comprehensive Analysis Reveals Distinct Immunological and Prognostic Characteristics of CD276/B7-H3 in Pan-Cancer.

Comprehensive Analysis Reveals Distinct Immunological and Prognostic Characteristics of CD276/B7-H3 in Pan-Cancer.

Journal: International journal of general medicine

Published: October 31, 2022

MCM2 in human cancer: functions, mechanisms, and clinical significance.

MCM2 in human cancer: functions, mechanisms, and clinical significance.

Journal: Molecular medicine (Cambridge, Mass.)

Published: August 21, 2022

Identification of Biomarkers for Predicting Ovarian Reserve of Primordial Follicle via Transcriptomic Analysis.

Identification of Biomarkers for Predicting Ovarian Reserve of Primordial Follicle via Transcriptomic Analysis.

Journal: Frontiers in genetics

Published: February 20, 2022

Involvement of Cancer Stem Cells in Chemoresistant Relapse of Epithelial Ovarian Cancer Identified by Transcriptome Analysis.

Involvement of Cancer Stem Cells in Chemoresistant Relapse of Epithelial Ovarian Cancer Identified by Transcriptome Analysis.

Journal: Journal of oncology

Published: December 23, 2021

miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy.

miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy.

Journal: Cancer cell international

Published: August 31, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026